Careers in Pharmacovigilance – A Stable Evergreen Industry

Gelatin-Capsules
Standard
Tags: Careers in Pharmacovigilance, Pharmacovigilance Training, Online Pharmacovigilance Courses

Pharmaceuticals is regarded as an evergreen industry. Drug safety or Pharmacovigilance is at the center stage of new drug development as well as postmarketing evaluation of approved drugs and devices. This creates a very vital niche for the pharmacovigilance industry inside the much larger and expanding pharmaceutical business. It would be apt to say that if pharmaceutical business is evergreen then pharmacovigilance is greener. Continue reading

Tropical Medicine in the Era of International Connectivity

Standard
Tags: Tropical Medicine, Tropical Medicine Courses, Tropical Medicine Diploma

In the modern era in which air travel has shrunken international boundaries, the study of tropical medicine has gained a more serious relevance for all nations. As a major example the Ebola virus disease (EVD) epidemic that surfaced in early 2014 has brought to limelight the concerns regarding the rapidity at which infectious diseases can cross distant borders and the effect they can have internationally. Continue reading

Importance of Tropical Medicine in Africa

Standard

Many health issues are specific to certain parts of the world based on their geography, socioeconomic and other factors.  A branch of international medicine also known has tropical medicine is involved in addressing issues related to health which mainly include communicable diseases common in the tropical and subtropical regions. Continue reading

Active drug safety surveillance improves public health (Drug Safety Surveillance)

Active drug safety surveillance
Standard

‘All drugs need to be safe and efficacious’ is an ideal goal and the objective of the pharmaceutical industry, researchers and the regulatory agencies is to come closer to this goal as much as possible. In the public health scenario the concepts of drug safety takes a higher priority due to a wider application of therapeutics outside of a controlled environment of clinical trials with rare and idiosyncratic effects surfacing with experience. Continue reading

Vulnerable subjects in clinical research

Standard

According to the dictionary definition, the word vulnerable means someone who is “exposed to the possibility of being attacked or harmed, either physically or emotionally”. So who constitutes the vulnerable population in Clinical Research and why do we need to protect them? To answer this question first, let’s take a brief look at the history of research abuse. Continue reading

Informed Consent Procedure in Clinical Trials

Informed Consent Procedure in clinical trails
Standard

Informed Consent in clinical trial is often the most important part of clinical trial and sometimes neglected too, resulting in serious consequences, for the patient, the doctor involved in the trial and the pharmaceutical company sponsoring the trial. Which brings us to the question of what exactly is an Informed Consent Procedure? It is process wherein the patient is made known details about the clinical trial and is asked whether he / she is willing to participate in the trial voluntarily. Doctors have a duty to fully explain the risk and the consequences of the participating in the clinical trial to the potential subject. Informed consent in a term used both in medical and legal terms. Continue reading

Development of Malaria Vaccine in Africa

Standard

Malaria continues to be widespread disease in killing more than 2 million people annually in Africa. The sub Saharan desert registers the most number of cases of malaria with a whopping 90%.  The World Health Organization, estimates that in the year 2010, malaria killed an estimated 660000 people, mostly children. It is estimated by the WHO that a children dies of malaria every minute in Africa. Africa accounts for over a 40% of deaths globally. Hence it is very important and the need of the hour to develop a vaccine against malaria in Africa. Continue reading

The Microdosing Concept in Clinical Trials

Standard

Every professional in Clinical Trials will agree to the fact that clinical trials are an expensive, long and very complex activity. Sometimes it takes 10 to 15 years and billions of dollars for pharmaceutical companies to get their product marketed.  Statistics have confirmed reports that the number of molecules which enter the market to become potential drugs of the future have declined or have become static during the past 10 years. One of the main reasons of failure of drugs is during their initial development cycle wherein pre clinical studies are done on animals, prior to human trials, drug metabolism pathways may differ. To address this issue, a relatively new concept has been introduced by the name of “Microdosing” or Phase 0. Continue reading

Major Breakthrough for Scientists as “Antibiotics Resistance Breaker” is all set for Phase III Trials

Standard

Antibiotic resistance is defined as the infection which does not respond to a particular drug as a result of bacteria changes that make the infection immune to the drug. The drug resistance phenomenon is a huge source of concern with the doctors, physicians and scientists all over the world. If this continues, and if sources are to be believed, then we would not be left with any antibiotics in the next 20 years. If sources are to be believed, we might have soon an antibiotic resistance breaker amongst us as the compound is all set for a phase III trial. Continue reading